1 completed, 1 not yet recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
Follow RSV: new trials by email Literature Review of RSV trials Research Report on RSV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine Low-dose RSV mRNA vaccine, High-dose RSV mRNA vaccine, Placebo - RSV, mRNA Vaccine | Phase 1 | Not yet recruiting | Sinovac Biotech Co., Ltd | 60 | 2026-03-09 | 2026-02-18 |
| A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old mRNA-1010, mRNA-1345, mRNA-1273.214 - SARS-CoV-2, Influenza | Phase 1 | Completed | ModernaTX, Inc. | 392 | 2022-10-14 | 2024-03-08 |
COVID-19 (1) · Coronavirus Infections (1) · Influenza, Human (1) · Virus Diseases (1)
Coronaviridae Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Orthomyxoviridae Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
mRNA-1010 influenza vaccine (1) · mRNA-1273.214 COVID-19 vaccine (1) · mRNA-1345 respiratory syncytial virus vaccine (1)
ModernaTX, Inc. (1) · Sinovac Biotech Co., Ltd (1)
Australia (1) · China (1) · United Kingdom (1) · United States (1)